In the BioHarmony Drug Report Database

"Preview" Icon

Linezolid

Linezolid, Zyvox (linezolid) is a small molecule pharmaceutical. Linezolid was first approved as Linezolid on 2000-04-18. It is used to treat bacterial infections, bacterial pneumonia, bacterial skin diseases, soft tissue infections, and staphylococcal infections amongst others in the USA. It is known to target amine oxidase [flavin-containing] A and amine oxidase [flavin-containing] B. Zyvox’s patents are valid until 2021-03-15 (FDA).

 

Trade Name

 

Linezolid, Zyvox
 

Common Name

 

linezolid
 

ChEMBL ID

 

CHEMBL126
 

Indication

 

bacterial infections, bacterial pneumonia, bacterial skin diseases, soft tissue infections, staphylococcal infections, streptococcal infections
 

Drug Class

 

Oxazolidinone antibacterials

Image (chem structure or protein)

Linezolid structure rendering